Juan Carlos García-Pagán
Publicacions destacades
-
Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease
Autors: Hernández-Gea V, Campreciós G, Betancourt F, Pérez-Campuzano V, Seijo S, Díaz A, Gallego-Durán R, Olivas P, Orts L, Magaz M, Baiges A, Turon F, Sidorova J, Romero-Gómez M, Lozano JJ, García-Pagán JC .Referència: Journal Of Hepatology 2021. -
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Autors: Nicoar?-Farc?u O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Thabut D, Fan D, Hernández-Gea V, García-Pagán JC, Preemptive TIPS Individual Data Metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups.Referència: Gastroenterology 2021. -
Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
Autors: Magaz M, Alvarez-Larrán A, Colomer D, López M, Turon F, Cervantes F, Virginia-Hernández-Gea , García-Pagán JC .Referència: Journal Of Hepatology 2021. -
Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study
Autors: Baiges A, Turon F, Simón-Talero M, Tasayco S, Bueno J, Zekrini K, Plessier A, Franchi-Abella S, Guerin F, Mukund A, Eapen CE, Goel A, Shyamkumar NK, Coenen S, De Gottardi A, Majumdar A, Onali S, Shukla A, Carrilho FJ, Nacif L, Primignani M, Tosetti G, La Mura V, Nevens F, Witters P, Tripathi D, Tellez L, Martínez J, Álvarez-Navascués C, Fraile López ML, Procopet B, Piscaglia F, de Koning B, Llop E, Romero-Cristobal M, Tjwa E, Monescillo-Francia A, Senzolo M, Perez-LaFuente M, Segarra A, Sarin SK, Hernández-Gea V, Patch D, Laleman W, Hartog H, Valla D, Genescà J, García-Pagán JC, REHEVASC, VALDIG an EASL consortium, Abernethy group.Referència: Hepatology 2020. -
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis
Autors: Reverter E, Lozano JJ, Alonso C, Berzigotti A, Seijo S, Turon F, Baiges A, Martínez-Chantar ML, Mato JM, Martínez-Arranz I, La Mura V, Hernández-Gea V, Bosch J, García-Pagán JC .Referència: Liver International 2019. -
Porto-sinusoidal vascular disease: proposal and description of a novel entity
Autors: De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC, VALDIG group.Referència: Lancet Gastroenterology & Hepatology 2019. -
Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis
Autors: Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R .Referència: Faseb Journal 2019. -
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
Autors: Reverter E, Cirera I, Albillos A, Debernardi-Venon W, Abraldes JG, Llop E, Flores A, Martínez-Palli G, Blasi A, Martínez J, Turon F, García-Valdecasas JC, Berzigotti A, de Lacy AM, Fuster J, Hernández-Gea V, Bosch J, García-Pagán JC .Referència: Journal Of Hepatology 2019. -
Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.
Autors: Silva-Junior G, Turon F, Baiges A, Cerda E, García-Criado Á, Blasi A, Torres F, Hernandez-Gea V, Bosch J, Garcia-Pagan JC .Referència: Gastroenterology 2017. -
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
Autors: Carlos Garcia-Pagan, Juan; Caca, Karel; Bureau, Christophe; Laleman, Wim; Appenrodt, Beate; Luca, Angelo; Abraldes, Juan G; Nevens, Frederik; Vinel, Jean Pierre; Moessner, Joachim; Bosch, Jaime.Referència: New England Journal Of Medicine 2010.
Projectes destacats
-
Estudio prospectivo, multicentrico y abierto para evaluar la eficacia del esmolol en la identificación precoz de las alteraciones cardiovasculares inducidas por la cirrosis, la diabetes mellitus y los tratamientos cardiotoxicos
Finançador: ISCIII (Instituto de Salud Carlos III)-Subdireccion General de EvaluacionCodi: ICI20/00011Durada: 01/11/2020 - 31/10/2023 -
Caracterización de la cirrosis en regresión. Identificación de vías moleculares clave y nuevas estrategias terapéuticas para su potenciación.
Investigador/a principal: Juan Carlos García PagánFinançador: Ministerio de Ciencia, Iinovación y Universidades.Codi: PID2019-105148RB-I00Durada: 01/06/2020 - 31/05/2023 -
A Phase II, Single-arm, Open-Label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients withDecompensated Cirrhosis
Investigador/a principal: Juan Carlos García PagánFinançador: Noorik Biopharmaceuticals AGDurada: 30/07/2019 - 31/05/2021 -
Hemodinàmica hepàtica i hipertensió portal. AGAUR_SGR17_00517
Investigador/a principal: Juan Carlos García PagánFinançador: AGAUR ( Agència de Gestió d'Ajuts Universitaris i de la Recerca)Codi: SGR17_00517Durada: 01/01/2017 - 30/09/2021 -
Prognostic factors to identify patients with cirrhosis surviving an acute bleeding episode at high-risk of variceal rebleeding and death during follow-up
Investigador/a principal: Juan Carlos García PagánDurada: 01/01/2019 - 31/12/2021